I agree that this site is using cookies. You can find further informations here.
X
Awni, Beatriz M
~ 200  results:
Search for persons X
?
1

Interplay between Tumor Mutational Burden and Mutational Pr..:

Xavier, Camila B. ; Lopes, Carlos Diego H. ; Awni, Beatriz M....
Cancers.  14 (2022)  21 - p. 5433 , 2022
Link: https://doi.org/10.3390/..
 
?
2

Interplay between Tumor Mutational Burden and Mutational Pr..:

Xavier, Camila B ; Lopes, Carlos Diego H ; Awni, Beatriz M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657500/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Interplay between Tumor Mutational Burden and Mutational Pr..:

Camila B. Xavier ; Carlos Diego H. Lopes ; Beatriz M. Awni...
https://www.mdpi.com/2072-6694/14/21/5433.  , 2022
Link: https://doi.org/10.3390/..
 
?
4

Interplay between Tumor Mutational Burden and Mutational Pr..:

Camila B. Xavier ; Carlos Diego H. Lopes ; Beatriz M. Awni...
Cancer Biomarkers.  , 2022
Link: https://doi.org/10.3390/..
 
?
5

Principles of Clinical Oncology and Systemic Treatments:

, In: Oncodermatology,
Awni, Beatriz Mendes ; Queiroz, Marcello Moro ; dos Santos Fernandes, Gustavo. - p. 225-246 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Basal Cell Carcinoma:

, In: Oncodermatology,
Awni, Beatriz Mendes ; Ferrer, Suzy Maria Rabello ; Molina, André Sapata... - p. 315-330 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Exacerbated Renal and Hematologic Toxicities to Ifosfamide ..:

Awni, Beatriz Mendes ; Holanda Lopes, Carlos Diego ; Harada, Guilherme...
Case Reports in Oncology.  15 (2022)  1 - p. 170-175 , 2022
Link: https://doi.org/10.1159/..
 
?
8

Methotrexate Dose in Patients With Early Rheumatoid Arthrit..:

Goss, Sandra L. ; Klein, Cheri E. ; Jin, Ziyi...
Clinical Therapeutics.  40 (2018)  2 - p. 309-319 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Industry Perspective on Standardizing Food-Effect Studies f..:

Marroum, Patrick J. ; Nuthalapati, Silpa ; Parikh, Apurvasena...
Clinical Pharmacokinetics.  57 (2018)  8 - p. 901-909 , 2018
Link: https://doi.org/10.1007/..
 
?
10

Application of Exposure-Response Analyses to Establish the ..:

Polepally, Akshanth R. ; Wang, Haoyu ; Marroum, Patrick J....
The AAPS Journal.  19 (2017)  5 - p. 1523-1535 , 2017
Link: https://doi.org/10.1208/..
 
?
11

Clinical Pharmacokinetics of Paritaprevir:

Menon, Rajeev M. ; Polepally, Akshanth R. ; Khatri, Amit..
Clinical Pharmacokinetics.  56 (2017)  10 - p. 1125-1137 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Dose- and Formulation-Dependent Non-Linear Pharmacokinetic ..:

Polepally, Akshanth R. ; Mensing, Sven ; Khatri, Amit...
Clinical Pharmacokinetics.  55 (2016)  9 - p. 1091-1101 , 2016
Link: https://doi.org/10.1007/..
 
?
13

145 Systematic delivery approach at 37 weeks of gestation i..:

Awni, Beatriz Mendes ; Rahal, Mariana Abduch ; Fontes, Arthur Barros...
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health.  6 (2016)  3 - p. 251-252 , 2016
Link: https://doi.org/10.1016/..
 
?
14

136 Systematic delivery approach at 37 weeks of gestation i..:

Audi, Lorena Fernandes ; Rahal, Mariana Abduch ; Fontes, Arthur Barros...
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health.  6 (2016)  3 - p. 247-248 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Population pharmacokinetics of paritaprevir, ombitasvir, da..:

Mensing, Sven ; Eckert, Doerthe ; Sharma, Shringi...
British Journal of Clinical Pharmacology.  83 (2016)  3 - p. 527-539 , 2016
Link: https://doi.org/10.1111/..
 
1-15